Cordant Inc’s Organon & Co OGN Stock Holding History

Cordant Inc’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10	Closed	-$146	–	123
2023 Q4	$146	Buy	+10	New	+$136	﹤0.01%	152
2022 Q2	–	Sell	-47	Closed	-$2K	–	884
2022 Q1	$2K	Buy	+47	New	+$1.61K	﹤0.01%	721

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cordant Inc's OGN Position: Q1 2024 in Review

Cordant Inc sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 10 shares — an estimated $146 sold.

Cordant Inc first reported a position in OGN in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

Cordant Inc reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
Cordant Inc sold 10 Organon & Co shares in Q1 2024, an estimated $146.
Cordant Inc first reported a position in Organon & Co in Q1 2022 and held it in 2 quarters.
Cordant Inc's Organon & Co position peaked at $2K in Q1 2022.
720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Cordant Inc's 13F filing for Q1 2024, filed 16 Apr 2024.